FDA Approved: TIGECYCLINE — Supplemental Application (Sandoz Inc)

View source ↗

Summary

FDA approved Sandoz Inc's supplemental application for tigecycline, a generic antibiotic. This action concerns the ANDA for tigecycline (ANDA 091620).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Community-acquired Bacterial Pneumonia
• Complicated Intra-abdominal Infections
• Complicated Skin and Skin Structure Infections

Drugs mentioned

• Tigecycline (tigecycline)

Snippet

SUPPL AP for TIGECYCLINE (TIGECYCLINE)